Segment Information (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Summary of Information by Reportable Segments

The following table presents information about the Company’s reportable segments for the three and six months ended June 30, 2022 and 2021 (in thousands):

	Three Months Ended June 30,
	2022									2021
	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total
External revenues	$	3,535		$	7,926		$	11,461		$	5,709		$	7,802		$	13,511
Operating expenses		109,709			20,113			129,822			98,553			15,508			114,061
Operating loss		(106,174	)		(12,187	)		(118,361	)		(92,844	)		(7,706	)		(100,550	)
Unrestricted cash		63,470			6,875			70,345			72,252			5,039			77,291

	Six Months Ended June 30,
	2022									2021
(in thousands)	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total
External revenues	$	15,107		$	14,738		$	29,845		$	12,978		$	14,788		$	27,766
Operating expenses		219,359			35,730			255,089			180,430			32,791			213,221
Operating loss		(204,252	)		(20,992	)		(225,244	)		(167,452	)		(18,003	)		(185,455	)
Unrestricted cash		63,470			6,875			70,345			72,252			5,039			77,291